TNFRSF11A Antibody (OAPB00460)

Data Sheet
 
Product Number OAPB00460
Product Page www.avivasysbio.com/tnfrsf11a-antibody-oapb00460.html
Name TNFRSF11A Antibody (OAPB00460)
Molecular Weight Predicted: 36kD Observed: 36 kD
Conjugation Unconjugated
NCBI Gene Id 8600
Host Rabbit
Clonality Polyclonal
Concentration 1 mg/ml
Gene Full Name TNF superfamily member 11
Alias Symbols CD254;hRANKL2;ODF;OPGL;OPTB2;osteoclast differentiation factor;osteoprotegerin ligand;RANKL;receptor activator of nuclear factor kappa B ligand;Receptor activator of nuclear factor kappa-B ligand;sOdf;TNF-related activation-induced cytokine;TNLG6B;TRANCE;tumor necrosis factor (ligand) superfamily, member 11;tumor necrosis factor ligand 6B;tumor necrosis factor ligand superfamily member 11;tumor necrosis factor superfamily member 11.
Product Format Liquid. sRANK Ligand Antibody is supplied in PBS containing 0.02% sodium azide.
Reference Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem.1997; 272:25190-4.;Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397:315-23.;Weitzmann MN, Cenci S, Rifas L, et al. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000; 96:1873-8.;Bharti AC, Takada Y, Shishodia S, et al. Evidence that receptor activator of the nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J. Biol. Chem.2004; 279:6065-76.
Description of Target Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy (PubMed:22664871). Induces osteoclastogenesis by activating multiple signaling pathways in osteoclast precursor cells, chief among which is induction of long lasting oscillations in the intracellular concentration of Ca (2+) resulting in the activation of NFATC1, which translocates to the nucleus and induces osteoclast-specific gene transcription to allow differentiation of osteoclasts. During osteoclast differentiation, in a TMEM64 and ATP2A2-dependent manner induces activation of CREB1 and mitochondrial ROS generation necessary for proper osteoclast generation (By similarity).
Reconstitution and Storage sRANK Ligand antibody can be stored at 4C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Datasheets/Manuals Printable datasheet for TNFRSF11A Antibody (OAPB00460) (OAPB00460)
Additional Information Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Application Info sRANK-L antibody can be used for detection of sRANK-L by Western blot at 0.25 - 0.5 ug/ml. (Optimal dilution should be determined by user)
Blocking Peptide For anti-TNFRSF11A (OAPB00460) antibody is Catalog # OEPB02570
Immunogen Anti-sRANK-L antibody (3963) was raised against a peptide corresponding to 14 amino acids near the center of human sRANK-L. The immunogen is located within amino acids 140-190 of sRANK-L.
Uniprot ID O14788
Protein Name Tumor necrosis factor ligand superfamily member 11|tumor necrosis factor ligand superfamily member 11 isoform 1 [Homo sapiens]
Protein Accession # https://www.ncbi.nlm.nih.gov/protein/NP_003692
Purification Affinity Purified
Nucleotide Accession # NM_001270949.1; NM_001270950.1; NM_001270951.1; NM_001278268.1; NM_003839.3
Gene Symbol TNFSF11
Predicted Species Reactivity Human|Mouse|Rat
Application Enzyme-linked immunosorbent assay|Immunohistochemistry-Paraffin|Western blot
Predicted Homology Based on Immunogen Sequence Human; Mouse; Rat
Image 1
rat liver
Western blot analysis of sRANK-L in rat liver tissue lysate with sRANK-L antibody at (A) 0.25 and (B) 0.5 ug/mL.
Image 2
human liver
Immunohistochemistry of sRANK-L in human liver tissue with sRANK-L antibody at 5 ug/mL.
 

AVIVA SYSTEMS BIOLOGY manufactures and sells quality antibody products covering genome wide proteins.

AVIVA SYSTEMS BIOLOGY
10211 Pacific Mesa Blvd, Ste 401, San Diego, CA 92121 USA | Tel: (858)552-6979 | info@avivasysbio.com